IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-κB is decisively involved in the expression of IL-9

Journal of Immunology

Volumn 166, Issue 7, 2001, Pages 4391-4398

  Stassen, M ^a   Muller C ^a   Arnold, M ^a   Hultner L ^a   Klein Hessling, S ^a   Neudorfl C ^a   Reineke, T ^a   Serfling, E ^a   Schmitt, E ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 9; LIPOPOLYSACCHARIDE;

ALLERGY; ANIMAL CELL; ARTICLE; ASSAY; BINDING SITE; BONE MARROW; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CONSTRUCT; IMMUNITY; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0035313207     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.7.4391     Document Type: Article

References (66)

1. Mast cells
2. Mast cells as sentinels of innate immunity
3. Mast cells and basophils in innate immunity
4. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide
5. CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi
6. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fcε receptor 1 crosslinking in cultured mast cells
7. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9)
8. + T cells but is not a general T cell growth factor
9. Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40)
10. Interleukin 9 and its receptor: An overview of structure and function
11. In activated mast cells, IL-1 upregulates the production of several Th2-related cytokines including IL-9
12. Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development
13. Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4
14. Partial purification of a mast cell growth-enhancing activity and its separation from IL-3 and IL-4
15. Interleukin-9 is involved in host protective immunity to intestinal nematode infection
16. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris
17. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice
18. Interleukin 9: A candidate gene for asthma
19. Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population
20. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
21. IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthma
22. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies
23. A family of small inducible proteins secreted by leukocytes are members of a new super-family that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes
24. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function
25. Activated mast cells produce interleukin 13
26. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
27. Interleukin-13: Central mediator of allergic asthma
28. Requirement for IL-13 independently of IL-4 in experimental asthma
29. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
30. Induction of CD14 expression in Lpsn, Lpsd and tumor necrosis factor receptor-deficient mice
31. Characterization of hemopoietic cell populations from human cord blood expressing c-kit
32. A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules
33. 2+ channel of basophils opening upon immunological stimulus
34. Generation of hybridomas secreting murine reaginic àntibodies of anti- DNP specificity
35. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE
36. 4+ T cells, genomic organization, and comparison with the mouse gene
37. cAMP-induced NF-κB (p50/re1B) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation
38. Set of optimized luciferase reporter gene plasmids compatible with widely used CAT vectors
39. HMG 1(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells
40. Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an Nf-κB-like factor to a promoter element
41. Murine bone marrow-derived mast cells as potent producers of IL-9: Costimulatory function of IL-10 and kit ligand in the presence of IL-1
42. Cutting edge: Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein
43. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB
44. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity
45. Multiple transcription factors are required for activation of human interleukin 9 gene in T cells
46. Toll signaling pathways in the innate immune response
47. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
48. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
49. The IL-1 receptor/toll-like receptor super-family: Crucial receptors for inflammation and host defense
50. Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NFκB and AP-1 in human astrocytoma U373 cells
51. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-κB) which are involved in IL-6 regulation
52. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn
53. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population
54. IL-9 pathway in asthma: New therapeutic targets for allergic inflammatory disorders
55. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils
56. Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13
57. Interleukin-13 and tumour necrosis factor-α synergistically induce eotaxin production in human nasal fibroblasts
58. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
59. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice
60. Inflammatory response to acute inhalation of endotoxin in asthmatic patients
61. Protective effect of sodium cromoglycate on lipopolysaccharide-induced bronchial obstruction in asthmatics
62. Bacterial infection as an important triggering factor in bronchial asthma
63. Asthma and endotoxin: Lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment
64. CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma
65. Soluble CD14 in children with status asthmaticus
66. NF-κB/Re1 transcription factors: C-Re1 promotes airway hyperresponsiveness and allergic pulmonary inflammation